Induction of IDO-1 by Immunostimulatory DNA Limits Severity of Experimental Colitis
Open Access
- 1 April 2010
- journal article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 184 (7), 3907-3916
- https://doi.org/10.4049/jimmunol.0900291
Abstract
The chronic inflammatory bowel diseases are characterized by aberrant innate and adaptive immune responses to commensal luminal bacteria. In both human inflammatory bowel disease and in experimental models of colitis, there is an increased expression of the enzyme IDO. IDO expression has the capacity to exert antimicrobial effects and dampen adaptive immune responses. In the murine trinitrobenzene sulfonic acid model of colitis, inhibition of this enzyme leads to worsened disease severity, suggesting that IDO acts as a natural break in limiting colitis. In this investigation, we show that induction of IDO-1 by a TLR-9 agonist, immunostimulatory (ISS) DNA, critically contributes to its colitis limiting capacities. ISS DNA induces intestinal expression of IDO-1 but not the recently described paralog enzyme IDO-2. This induction occurred in both epithelial cells and in subsets of CD11c+ and CD11b+ cells of the lamina propria, which also increase after ISS-oligodeoxynucleotide. Signaling required for intestinal IDO-1 induction involves IFN-dependent pathways, as IDO-1 was not induced in STAT-1 knockout mice. Using both the trinitrobenzene sulfonic acid and dextran sodium sulfate models of colitis, we show the importance of IDO-1s induction in limiting colitis severity. The clinical parameters and histological correlates of colitis in these models were improved by administration of the TLR-9 agonist; however, when the function of IDO is inhibited, the colitis limiting effects of ISS-oligodeoxynucleotide were abrogated. These findings support the possibility that targeted induction of IDO-1 is an approach deserving further investigation as a therapeutic strategy for diseases of intestinal inflammation.Keywords
This publication has 55 references indexed in Scilit:
- IL-27 Regulates Homeostasis of the Intestinal CD4+ Effector T Cell Pool and Limits Intestinal Inflammation in a Murine Model of ColitisPublished by The American Association of Immunologists ,2009
- Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathwayThe International Journal of Biochemistry & Cell Biology, 2009
- Toll-like receptors and intestinal epithelial repairCurrent Opinion in Gastroenterology, 2008
- Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cellsBlood, 2008
- Unravelling the pathogenesis of inflammatory bowel diseaseNature, 2007
- Myd88-dependent positioning of Ptgs2-expressing stromal cells maintains colonic epithelial proliferation during injuryJCI Insight, 2007
- Cox-2 Is Regulated by Toll-Like Receptor-4 (TLR4) Signaling: Role in Proliferation and Apoptosis in the IntestineGastroenterology, 2006
- Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF- B decoy oligonucleotidesJCI Insight, 2005
- Enhancement of Innate Immunity againstMycobacterium aviumInfection by Immunostimulatory DNA Is Mediated by Indoleamine 2,3-DioxygenaseInfection and Immunity, 2001
- A genetic linkage map of the long arm of human chromosome 22Genomics, 1989